R. Ramelmeier

Chief Tech/Sci/R&D Officer presso ADVERUM BIOTECHNOLOGIES, INC.

Patrimonio netto: 59 014 $ in data 31/03/2024

62 anni

Health Technology

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Laurent Fischer	M	60	ADVERUM BIOTECHNOLOGIES, INC.	4 anni
Clarence Machado	M	60	ADVERUM BIOTECHNOLOGIES, INC.	7 anni
Randy Meier	M	65	BIOMARIN PHARMACEUTICAL INC.	18 anni
Peter Soparkar	M	53	ADVERUM BIOTECHNOLOGIES, INC.	5 anni
Prathyusha Durabaibu	F	46	SANGAMO THERAPEUTICS, INC.	5 anni
Gregory Davis	M	-	SANGAMO THERAPEUTICS, INC.	4 anni
Philip Lo Scalzo	M	-	BIOMARIN PHARMACEUTICAL INC.	17 anni
Louise Wilkie	F	-	SANGAMO THERAPEUTICS, INC.	4 anni
Anand Reddi	M	42	ADVERUM BIOTECHNOLOGIES, INC.	-
Soo Hong	F	52	ADVERUM BIOTECHNOLOGIES, INC.	2 anni
Heikki Jouttijärvi	M	-	ADVERUM BIOTECHNOLOGIES, INC.	4 anni
John Markels	M	58	SANGAMO THERAPEUTICS, INC.	4 anni
Rabia Ozden	M	56	ADVERUM BIOTECHNOLOGIES, INC.	2 anni
Karen Smith	M	56	SANGAMO THERAPEUTICS, INC.	6 anni
Scott Michael Whitcup	M	64	ADVERUM BIOTECHNOLOGIES, INC.	4 anni
Dawn Svoronos	F	70	ADVERUM BIOTECHNOLOGIES, INC.	4 anni
Stuart Bunting	M	-	BIOMARIN PHARMACEUTICAL INC.	16 anni
Mark Lupher	M	53	ADVERUM BIOTECHNOLOGIES, INC.	5 anni
Linda Rubinstein	F	58	ADVERUM BIOTECHNOLOGIES, INC.	2 anni
James Meyers	M	58	SANGAMO THERAPEUTICS, INC.	5 anni
V. Lawlis	M	72	BIOMARIN PHARMACEUTICAL INC.	17 anni
Jim Scopa	M	65	ADVERUM BIOTECHNOLOGIES, INC.	5 anni
C. Nicholson	M	68	ADVERUM BIOTECHNOLOGIES, INC.	1 anni
John Rakow	M	67	ADVERUM BIOTECHNOLOGIES, INC.	3 anni
Reed Tuckson	M	73	ADVERUM BIOTECHNOLOGIES, INC.	3 anni
Kenneth Hillan	M	63	SANGAMO THERAPEUTICS, INC.	4 anni
Marc K. Hellerstein	M	72	University of California, Berkeley	37 anni
Star Seyedkazemi	M	50	ADVERUM BIOTECHNOLOGIES, INC.	2 anni
Courtney Beers	M	54	SANGAMO THERAPEUTICS, INC.	2 anni
Eduardo Von Pervieux	M	-	BIOMARIN PHARMACEUTICAL INC.	16 anni
Bill Tan	M	-	ADVERUM BIOTECHNOLOGIES, INC.	3 anni
Henry Fuchs	M	66	BIOMARIN PHARMACEUTICAL INC.	15 anni
Nathalie Dubois Stringfellow	M	-	SANGAMO THERAPEUTICS, INC.	5 anni
L. Stephen Coles	M	72	University of California, Berkeley	36 anni
Romuald Corbau	M	55	ADVERUM BIOTECHNOLOGIES, INC.	-
Brad Glasscock	M	-	BIOMARIN PHARMACEUTICAL INC.	12 anni
Stuart Russell	M	-	University of California, Berkeley	38 anni
Dena House	F	-	ADVERUM BIOTECHNOLOGIES, INC.	5 anni
Donald A. McQuade	M	82	University of California, Berkeley	38 anni
Christina Duckworth Romer	M	65	University of California, Berkeley	36 anni
Carla Fiankan	F	-	ADVERUM BIOTECHNOLOGIES, INC.	-
Amy Wireman	F	-	BIOMARIN PHARMACEUTICAL INC.	11 anni
Peg Horn	M	61	SANGAMO THERAPEUTICS, INC.	2 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Costas Christos Hamakiotes	M	-	University of California, Berkeley	9 anni
Carl Perez	M	-	University of California, Berkeley	8 anni
Qing Huang	M	62	University of California, Berkeley	6 anni
Kamal H. Khayat	M	-	University of California, Berkeley	7 anni
Gary Loeb	M	54	SANGAMO THERAPEUTICS, INC.	2 anni
Kathy Yi	F	52	SANGAMO THERAPEUTICS, INC.	2 anni
William Ringo	M	78	SANGAMO THERAPEUTICS, INC.	8 anni
Paul Jacobs	M	61	University of California, Berkeley	9 anni
Daniel Cotton	M	-	University of California, Berkeley	3 anni
Lou Forster	M	63	The Johns Hopkins University	5 anni
Robert M. Califf	M	72	PORTOLA PHARMACEUTICALS, INC.	3 anni
Richard G. Wallace	M	-	University of California, Berkeley	7 anni
Jeffrey L. Streator	M	60	University of California, Berkeley	5 anni
Edward Rebar	M	56	SANGAMO THERAPEUTICS, INC.	22 anni
Pierre Breber	M	59	University of California, Berkeley	5 anni
Matthew B. Hemington	M	-	University of California, Berkeley	8 anni
Sona Saira Ramasastry	F	48	SANGAMO THERAPEUTICS, INC.	10 anni
Ori Sasson	M	-	University of California, Berkeley	6 anni
Sandra Shpilberg	F	48	BIOMARIN PHARMACEUTICAL INC.	9 anni
Gary May	M	59	University of California, Berkeley	5 anni
W. Richey Neuman	M	-	PORTOLA PHARMACEUTICALS, INC.	3 anni
Michael Holmes	M	-	SANGAMO THERAPEUTICS, INC.	17 anni
Dave Butler	M	-	University of California, Berkeley	7 anni
Julianto Sidarto	M	-	The Johns Hopkins University	5 anni
Nat Simons	M	-	University of California, Berkeley	10 anni
Adam Rossman	M	57	University of California, Berkeley	6 anni
Mark McClung	M	61	SANGAMO THERAPEUTICS, INC.	4 anni
Jason Fontenot	M	54	SANGAMO THERAPEUTICS, INC.	5 anni
Brigit Riley	M	46	SANGAMO THERAPEUTICS, INC. ADVERUM BIOTECHNOLOGIES, INC.	9 anni
Edward Conner	M	51	SANGAMO THERAPEUTICS, INC. BIOMARIN PHARMACEUTICAL INC.	5 anni
Ana Dolores Moura Carneiro de Novaes	M	62	University of California, Berkeley	4 anni
Ken Bate	M	73	BIOMARIN PHARMACEUTICAL INC.	7 anni
David Choi	M	-	University of California, Berkeley	5 anni
Nicholas G. Galakatos	M	66	PORTOLA PHARMACEUTICALS, INC.	12 anni
Stephen Dilly	M	64	SANGAMO THERAPEUTICS, INC.	10 anni
William Young	M	79	BIOMARIN PHARMACEUTICAL INC.	5 anni
David Stump	M	74	PORTOLA PHARMACEUTICALS, INC.	-
Dan Spiegelman	M	65	BIOMARIN PHARMACEUTICAL INC.	8 anni
Christopher Starr	M	71	BIOMARIN PHARMACEUTICAL INC.	9 anni
Dennis Fenton	M	72	PORTOLA PHARMACEUTICALS, INC.	-
Roger Jeffs	M	62	SANGAMO THERAPEUTICS, INC.	2 anni
Rick Bernstein	M	-	The Johns Hopkins University	8 anni
Eric Stonestrom	M	62	University of California, Berkeley	6 anni
Weijian Shan	M	70	University of California, Berkeley	4 anni
Tri Luu Pham	M	58	The Johns Hopkins University	5 anni
Anne Milne	F	-	The Johns Hopkins University	1 anni
Lisa Suennen	F	58	University of California, Berkeley	5 anni
Thomas B. Ottoboni	M	65	University of California, Berkeley	7 anni
Steven Mento	M	72	SANGAMO THERAPEUTICS, INC.	14 anni
Laura Brege	F	66	PORTOLA PHARMACEUTICALS, INC.	5 anni
Joseph Zakrzewski	M	60	SANGAMO THERAPEUTICS, INC.	5 anni
Mark Wood	M	57	BIOMARIN PHARMACEUTICAL INC.	9 anni
Thomas E. Tighe	M	-	University of California, Berkeley	7 anni
Weijie Yun	M	60	University of California, Berkeley	5 anni
Mark C. Holscher	M	-	University of California, Berkeley	7 anni
Jaideep Srivastava	M	-	University of California, Berkeley	4 anni
Fabio Romeo	M	-	University of California, Berkeley	4 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	100	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni